$0.00510
At close: May 15, 5:00 PM EST
$0.0172
0.0121237.25%
After Hours: Apr 6, 9:02 AM EST
Latest Pasithea Therapeutics Stock News | NASDAQ:KTTAW | Benzinga
Get the latest news on Pasithea Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Pasithea Therapeutics performance
Categories: All
Friday, September 27, 2024
Tuesday, January 02, 2024
Saturday, December 30, 2023
Thursday, August 11, 2022
Thursday, June 23, 2022
Wednesday, June 22, 2022
Tuesday, March 08, 2022
Thursday, February 03, 2022
Thursday, December 23, 2021
Tuesday, December 21, 2021
Tuesday, November 23, 2021
- Ault Global Holdings Founder Tweets '"Today w...PRO
- EXCLUSIVE: Pasithea Therapeutics CEO, Tiago R...PRO
- EXCLUSIVE: Pasithea Therapeutics CEO, Tiago R...PRO
- EXCLUSIVE: Pasithea Therapeutics CEO, Tiago R...PRO
- EXCLUSIVE: Pasithea Therapeutics CEO, Tiago R...PRO
- EXCLUSIVE: Pasithea Therapeutics' Subsidiary ...PRO
Wednesday, November 17, 2021
- EXCLUSIVE: Pasithea Therapeutics Says 'Ketamine, when used at sub-anesthetic doses, has been shown to be highly effective in treating some psychiatric disorders.'
- EXCLUSIVE: Pasithea Therapeutics' Wholly Owned Subsidiary Pasithea Clinics To Launch In-Home Intravenous Ketamine Therapy In New York City, Los Angeles, San Diego, And San Francisco To Expand Its International Footprint
